Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RET-US Cohort: Prospective Evaluation of an AI-Ultrasound Model for Detecting RET Gene Alterations and Predicting Lateral Cervical Lymph-Node Metastasis in Papillary Thyroid Carcinoma

NCT07042984 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT07042984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07042984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RET-US Cohort: Prospective Evaluation of an AI-Ultrasound Model for Detecting RET Gene Alterations and Predicting Lateral Cervical Lymph-Node Metastasis in Papillary Thyroid Carcinoma
Lead sponsor
Fujian Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
December 31, 2029
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic metastasis, papillary thyroid carcinoma, ret proto-oncogene mutation, thyroid neoplasms